Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks

EMBO Rep. 2009 Aug;10(8):887-93. doi: 10.1038/embor.2009.97. Epub 2009 Jun 26.

Abstract

Ataxia telangiectasia mutated (ATM), the deficiency of which causes a severe neurodegenerative disease, is a crucial mediator for the DNA damage response (DDR). As neurons have high rates of transcription that require topoisomerase I (TOP1), we investigated whether TOP1 cleavage complexes (TOP1cc)-which are potent transcription-blocking lesions-also produce transcription-dependent DNA double-strand breaks (DSBs) with ATM activation. We show the induction of DSBs and DDR activation in post-mitotic primary neurons and lymphocytes treated with camptothecin, with the induction of nuclear DDR foci containing activated ATM, gamma-H2AX (phosphorylated histone H2AX), activated CHK2 (checkpoint kinase 2), MDC1 (mediator of DNA damage checkpoint 1) and 53BP1 (p53 binding protein 1). The DSB-ATM-DDR pathway was suppressed by inhibiting transcription and gamma-H2AX signals were reduced by RNase H1 transfection, which removes transcription-mediated R-loops. Thus, we propose that Top1cc produce transcription arrests with R-loop formation and generate DSBs that activate ATM in post-mitotic cells.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Alpha-Amanitin / pharmacology
  • Animals
  • Ataxia Telangiectasia Mutated Proteins
  • Camptothecin / pharmacology
  • Cell Cycle Proteins / metabolism*
  • Cells, Cultured
  • DNA Breaks, Double-Stranded*
  • DNA Topoisomerases, Type I / metabolism*
  • DNA-Binding Proteins / metabolism*
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Flow Cytometry
  • Histones / metabolism
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Neurons / drug effects
  • Neurons / metabolism
  • Nuclear Proteins / metabolism
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Protein Serine-Threonine Kinases / metabolism*
  • Rats
  • Ribonuclease H / metabolism
  • Signal Transduction / drug effects
  • Trans-Activators / metabolism
  • Transcription, Genetic / genetics
  • Transcription, Genetic / physiology
  • Tumor Suppressor Proteins / metabolism*
  • Tumor Suppressor p53-Binding Protein 1

Substances

  • Adaptor Proteins, Signal Transducing
  • Alpha-Amanitin
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • H2AX protein, human
  • Histones
  • Intracellular Signaling Peptides and Proteins
  • MDC1 protein, human
  • Nuclear Proteins
  • Nucleic Acid Synthesis Inhibitors
  • TP53BP1 protein, human
  • Trans-Activators
  • Tumor Suppressor Proteins
  • Tumor Suppressor p53-Binding Protein 1
  • Dichlororibofuranosylbenzimidazole
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Protein Serine-Threonine Kinases
  • Ribonuclease H
  • ribonuclease HI
  • DNA Topoisomerases, Type I
  • Camptothecin